BofA raised the firm’s price target on Agilent to $130 from $129 and keeps a Buy rating on the shares. Like peers, Agilent’s FY24 guidance implies a steep second half sales ramp and while “a bit cautious” on the ramp given how FY23 unfolded across the sector, the fact that things didn’t get worse during fiscal Q4 “is encouraging,” the analyst tells investors in a post-earnings note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on A: